INVISION INLAB NGS SOLUTION: End-to-End Sample-to-Report Integration

The INVISION INLab NGS Solution integrates the complete Sample-to-Report NGS workflow. INB develops and manufactures the key components of the workflow, including automated nucleic acid extraction systems, NGS library preparation workstations, targeted NGS panels, and automated bioinformatics and reporting software. By integrating these components into a standardized workflow, INLab enables laboratories to streamline NGS testing, reduce manual operations, and improve workflow consistency and turnaround time.

INB offers targeted NGS panels for applications including solid tumors and liquid tumors. Its INVISION Leukemia NGS Solution, validated by Yale Medical Center and adopted by CAP-accredited laboratories, combines leukemia-related gene panels with INB’s proprietary DimerOff™ technology, which reduces primer-dimer formation and non-specific amplification to improve library quality and sequencing efficiency. The integrated solution supports molecular profiling, treatment decision-making, and disease monitoring for leukemia and other hematological malignancies.

A. Product High-light:
*Integrated Sample-to-Report Workflow
End-to-end NGS workflow covering nucleic acid extraction, library preparation, targeted panels, sequencing, bioinformatics, and reporting.

*In-House Developed Core Components
INB develops and manufactures the nucleic acid extraction system, library preparation workstation, NGS panels, and reporting software.

*Proprietary DimerOff™ Technology
Reduces primer-dimer formation and non-specific amplification to improve library quality and sequencing efficiency.

*Targeted Clinical NGS Panels
Supports applications in solid tumors, liquid biopsy, and hematological malignancies.

*INVISION Leukemia NGS Solution
Designed to support molecular profiling, treatment decision-making, and disease monitoring in leukemia and hematological malignancies.

*Standardized & Automated Workflow
Reduces manual operations and improves workflow consistency, reproducibility, and laboratory efficiency.

B. Unique selling propositioins:
*End-to-End Sample-to-Report Integration
Integrates 4 core in-house developed components: nucleic acid extraction, library preparation workstation, targeted NGS panels, and automated reporting software.

*~95% Primer-Dimer Reduction with DimerOff™
Proprietary DimerOff™ technology significantly reduces primer-dimer formation, improving library quality and sequencing efficiency.

*Turnaround Time Reduced from 14 Days to ≤3 Days
Standardized automation shortens the overall NGS testing workflow and improves laboratory efficiency.